
Study in São Paulo: Medicinal Cannabis Reduced Symptoms in 8 Simultaneous Comorbidities
Research conducted with 1,240 patients in São Paulo demonstrated significant symptom reduction in chronic pain, anxiety, insomnia, epilepsy, systemic inflammation, spasticity, depression and metabolic syndrome after 6 months of phytocannabinoid treatment.
1.240
Patients
8
Comorbidities
67%
Avg. improvement
6 meses
Duration
